Pay in 4 interest-free payments of $6.04 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
Evaluation of Melanotan-II, a superpotent cyclic melanotropic peptide in a pilot phase-I clinical study
With Sermorelin, some studies suggest that Sermorelin can promote the growth of some types of cancer, while others suggest that it could be utilised as a possible treatment for cancer
The robust weight loss combined with a well-tolerated safety profile reinforces our confidence in the clinical development programme as we advance to phase III trials. CT-388 is an important asset for unlocking the promise of our obesity pipeline, according to Roche, who added that the treatment is considered as a combination asset for petrelintide, an amylin analogue
Good Easy to navigate Great communication about shipping and tracking info
Contact us at [email protected]
Treatment decisions, including dosing and monitoring strategies, should be individualized in consultation between patients and their physicians
/assets/images/provider/photos/2764906.jpg)
US$ 27.34
US$ 25.57
US$ 23.26
US$ 27.99
US$ 25.39
US$ 23.89
